2025 annual financial data
Xenetic Biosciences 2025 Operating margin
Direct answer
Operating margin was -95.23%.
Operating income was -2,834,582 USD and net income was -2,680,860 USD.
Operating cash flow was -2,286,651 USD.
Get free Xenetic Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,976,411 USD
- Operating income
- -2,834,582 USD
- Net income
- -2,680,860 USD
- Operating cash flow
- -2,286,651 USD